Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Efficacy of Intranasal Oxytocin on Pain and Function Among Individuals Who Experience Chronic Pain: A Multisite, Placebo-controlled, Blinded, Sequential, Within-subjects Crossover Trial

NCT04903002 is registered in ClinicalTrials.gov with Memorial University of Newfoundland as lead sponsor.

NCT NCT04903002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04903002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Efficacy of Intranasal Oxytocin on Pain and Function Among Individuals Who Experience Chronic Pain: A Multisite, Placebo-controlled, Blinded, Sequential, Within-subjects Crossover Trial
Lead sponsor
Memorial University of Newfoundland
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
April 1, 2022
Completion date
March 31, 2026
Enrollment
336 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pain